NCT07389876 2026-02-05
G/GEJ
Fudan University
Recruiting
Clinical Trials
4 trialsNCT06663787 2025-11-28
HER2 CR
Nagoya City University
Active not recruiting
NCT05754502 2023-03-03
Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy
Consorzio Oncotech
Unknown
NCT04769050 2022-04-20
Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment
Fudan University
Unknown